{"id":"W4390754195","doi":"10.1016/j.ejca.2024.113530","title":"Safety profile of pembrolizumab monotherapy based on an aggregate safety evaluation of 8937 patients","year":2024,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"ca_institutions":"Toronto General Hospital; Princess Margaret Cancer Centre; University Health Network","funders":"National Cancer Institute","keywords":"Pembrolizumab; Discontinuation; Medicine; Adverse effect; Internal medicine; Clinical trial; Immune system; Cancer; Oncology; Immunotherapy; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002040584,0.0001372256,0.0003077479,0.0002146574,0.00002901555,0.00001185569,0.0001251273,0.00002623824,0.001185813],"category_scores_gemma":[0.00005499821,0.00009914389,0.0002200338,0.000241783,0.00007274382,0.0001218966,0.000007013711,0.0001831027,0.000004236006],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002723335,"about_ca_system_score_gemma":0.0005697799,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001682966,"about_ca_topic_score_gemma":0.000004374727,"domain_scores_codex":[0.9975654,0.0004930785,0.0007579338,0.0001458912,0.0009118102,0.000125904],"domain_scores_gemma":[0.9984018,0.00005028873,0.0005073756,0.0002215304,0.0007389088,0.00008007688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.03030584,0.0003185468,0.002209873,0.0001485828,0.0004074753,0.00002221482,0.0007226958,0.001242569,0.01742485,0.00001085956,0.00149458,0.9456919],"study_design_scores_gemma":[0.053455,0.01489864,0.6409525,0.008752449,0.001273279,0.00003686779,0.0001792292,0.02403857,0.07453129,0.00003371473,0.1813734,0.0004750709],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9779889,0.008652884,0.0003779239,0.000906727,0.001002346,0.0004775872,0.0001032763,0.0000168034,0.01047355],"genre_scores_gemma":[0.9975299,0.001383686,0.0002178462,0.0003286678,0.0002609263,0.000002217781,0.00001478995,0.00004534496,0.0002166263],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9452168,"threshold_uncertainty_score":0.9997272,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02423019230298953,"score_gpt":0.3202352319545786,"score_spread":0.2960050396515891,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}